ARCHIVES

AHRQ Draft Report Finds No Benefit For Biomarker Testing In Oncology

This article is from The Cancer Letter archive.

Vol. 36 No. 04 | February 5, 2010

Download PDF Visit The Full Archive

Related Articles

Cooperative Group Consolidation Unlikely To Save Money, NCI’s Doroshow Says

September 24, 2010

Tamoxfin Trial accrues 6,000, Problems with Minority accrual Remain

April 2, 1993

“Optimal Criteria,” For Hospitals Treating Cancer Patients Developed; NCI Won’t Try Forcing Changes

November 1, 1974

Isis 3521 Gets Fast-track Status For FDA Review.

December 1, 2000

In Brief: Kansas to Provide State Funds For Cancer Center; Meeting On Freestanding Centers In Philadelphia

May 22, 1987

Komen Board Approved Defunding Planned Parenthood, Says Karen Handel

February 10, 2012